GSK’s John Fleming on rethinking oncology from the ground upWhat if we could look at cancer treatment from a completely fresh perspective? This is the philosophy GSK’s Share XGSK’s John Fleming on rethinking oncology from the ground uphttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/gsks-john-fleming-on-rethinking-oncology-from-the-ground-up/
Safety fears deter parents from clinic visits for vaccinations during pandemic, says surveyParents’ willingness to vaccinate children has been boosted by the COVID-19 pandemic, but safety fears mean few are Share XSafety fears deter parents from clinic visits for vaccinations during pandemic, says surveyhttps://pharmaphorum.com/news/safety-fears-deter-parents-from-clinic-visits-for-vaccinations-during-pandemic-says-survey/
Sanofi and GSK join forces on coronavirus vaccineAs the world waits with bated breath for a coronavirus vaccine, two of the world’s biggest vaccine manufacturers, Share XSanofi and GSK join forces on coronavirus vaccinehttps://pharmaphorum.com/news/sanofi-and-gsk-join-forces-on-coronavirus-vaccine/
The power of crowdsourced R&DDrug R&D is still dogged by attrition, duplication and waste. Chas Bountra, chief scientist & head of the Share XThe power of crowdsourced R&Dhttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/crowdsourcing-rd/
AZ shares slide after warning over coronavirus impactShares in AstraZeneca were sharply down this morning after it warned that the hit from the COVID-19 coronavirus Share XAZ shares slide after warning over coronavirus impacthttps://pharmaphorum.com/news/az-shares-slide-after-warning-over-coronavirus-impact/
GSK licenses TB vaccine to Bill and Melinda Gates InstituteGlaxoSmithKline has licensed its potential tuberculosis vaccine to the Bill and Melinda Gates Medical Research Institute, saying this Share XGSK licenses TB vaccine to Bill and Melinda Gates Institutehttps://pharmaphorum.com/news/gsk-licenses-tb-vaccine-to-bill-and-melinda-gates-institute/
GSK finds synergies with global marketing strategyGSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content Share XGSK finds synergies with global marketing strategyhttps://pharmaphorum.com/views-and-analysis/gsk-finds-synergies-with-global-marketing-strategy/
ESMO 2019 roundupThe European Society for Medical Oncology (ESMO) is growing in stature, with an increasing number of oncology-focused pharma Share XESMO 2019 rounduphttps://pharmaphorum.com/views-analysis-oncology/esmo-2019-roundup/
GSK aims to get triple therapy approved for asthma in USGlaxoSmithKline and development partner Innoviva have filed a dossier with the FDA, in a bid to get their Share XGSK aims to get triple therapy approved for asthma in UShttps://pharmaphorum.com/news/gsk-bids-to-become-first-asthma-triple-therapy-on-the-us-market/
